Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 1
1988 1
1989 1
1990 2
1991 1
1992 2
1994 2
1995 1
1998 2
2000 1
2002 1
2003 1
2004 1
2005 4
2006 1
2007 3
2008 2
2010 2
2011 2
2013 1
2015 2
2016 2
2018 1
2019 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Extragonadal Embryonal Carcinoma"
Page 1
The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ, Huddart RA, Coleman N. Murray MJ, et al. Nat Rev Urol. 2016 Dec;13(12):715-725. doi: 10.1038/nrurol.2016.170. Epub 2016 Oct 18. Nat Rev Urol. 2016. PMID: 27754472 Review.
Furthermore, LDH is a very nonspecific biomarker. Consequently, seminomas and NSGCTs comprising a pure embryonal carcinoma subtype are generally negative for these conventional markers. ...A panel of four circulating microRNAs from these two clusters (miR-371a-3p, m …
Furthermore, LDH is a very nonspecific biomarker. Consequently, seminomas and NSGCTs comprising a pure embryonal carcinoma sub …
Poorly differentiated carcinoma and germ cell tumors.
Hainsworth JD, Greco FA. Hainsworth JD, et al. Hematol Oncol Clin North Am. 1991 Dec;5(6):1223-31. Hematol Oncol Clin North Am. 1991. PMID: 1663941 Review.
Although many questions remain unanswered, recent clinical and pathologic studies have shed considerable light on the subject of carcinoma of unknown primary site. It is now clear that some patients in this group have extragonadal germ cell tumors. ...It is clear th …
Although many questions remain unanswered, recent clinical and pathologic studies have shed considerable light on the subject of carcinom …
Treatment options for carcinoma in situ testis.
Mortensen MS, Gundgaard MG, Daugaard G. Mortensen MS, et al. Int J Androl. 2011 Aug;34(4 Pt 2):e32-6. doi: 10.1111/j.1365-2605.2011.01178.x. Epub 2011 Jun 9. Int J Androl. 2011. PMID: 21651575 Review.
Carcinoma in situ testis (CIS) is known as the precursor of germ cell cancer of the testis. ...Radiotherapy is recommended in patients with contralateral CIS. Orchidectomy should be offered in extragonadal germ cell cancer and CIS in one testicle, whereas patients w …
Carcinoma in situ testis (CIS) is known as the precursor of germ cell cancer of the testis. ...Radiotherapy is recommended in patient …
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH. Cheng L, et al. J Pathol. 2007 Jan;211(1):1-9. doi: 10.1002/path.2105. J Pathol. 2007. PMID: 17117392 Review.
Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentia …
Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripot …
Prognostic parameters for the management of advanced testis tumours.
Mickisch GH. Mickisch GH. Curr Opin Urol. 2000 Sep;10(5):465-71. doi: 10.1097/00042307-200009000-00017. Curr Opin Urol. 2000. PMID: 11005453 Review.
Traditional prognostic factors, on which most classification systems are based, include large tumour volume, the presence of liver, bone or brain metastasis, grossly elevated tumour markers and an extragonadal primary site, particularly in the mediastinum. Novel prognostic …
Traditional prognostic factors, on which most classification systems are based, include large tumour volume, the presence of liver, bone or …
Cytological spectrum of testicular malignancies with histopathological correlation: A retrospective analysis.
Kerkar A, Kundu R, Kaur A, Rohilla M, Gupta P, Gupta N, Srinivasan R, Kakkar N, Dey P. Kerkar A, et al. Diagn Cytopathol. 2023 Oct;51(10):646-653. doi: 10.1002/dc.25194. Epub 2023 Jul 14. Diagn Cytopathol. 2023. PMID: 37452481
The most common testicular malignancy is germ cell tumor. Extragonadal malignancies such as lymphomas are rare. Testicular fine-needle aspiration cytology (FNAC) in cancer is a bit controversial amidst fear of tumor seeding along the needle tract. ...Infiltration by leukem …
The most common testicular malignancy is germ cell tumor. Extragonadal malignancies such as lymphomas are rare. Testicular fine-needl …
PARP expression in germ cell tumours.
Mego M, Cierna Z, Svetlovska D, Macak D, Machalekova K, Miskovska V, Chovanec M, Usakova V, Obertova J, Babal P, Mardiak J. Mego M, et al. J Clin Pathol. 2013 Jul;66(7):607-12. doi: 10.1136/jclinpath-2012-201088. Epub 2013 Mar 13. J Clin Pathol. 2013. PMID: 23486608
Mean QSSD for each histological subtype was as follows: intratubular germ cell neoplasia unclassified (IGCNU)=18.000.00, embryonal carcinoma=9.625.64, seminoma=9.746.51, yolk sac tumour=7.87.20, teratoma=5.875.34, and choriocarcinoma=4.508.33. The PARP overexpressio …
Mean QSSD for each histological subtype was as follows: intratubular germ cell neoplasia unclassified (IGCNU)=18.000.00, embryonal …
Low Survival in Poor Prognosis Metastatic Germ Cell Cancer in Belarus.
Rolevich AI, Borodin DM, Rabcheuski AN, Ivanitskaya TA, Semenov SA, Artsiushkevich LV, Sukalinskaya AV, Zhavrid EA, Krasny SA, Konoplya NE, Polyakov SL. Rolevich AI, et al. JCO Glob Oncol. 2021 Jan;7:63-71. doi: 10.1200/GO.20.00473. JCO Glob Oncol. 2021. PMID: 33434070 Free PMC article.
MATERIALS AND METHODS: The consecutive cohort of patients with clinical stage IIb-III testicular GCC or extragonadal germ cell tumors who received treatment or consultation in our two centers between 2010 and 2015 was included. ...The patients were divided into seminoma an …
MATERIALS AND METHODS: The consecutive cohort of patients with clinical stage IIb-III testicular GCC or extragonadal germ cell tumors …
Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review.
Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE. Hoei-Hansen CE, et al. Ann Oncol. 2005 Jun;16(6):863-8. doi: 10.1093/annonc/mdi175. Epub 2005 Apr 8. Ann Oncol. 2005. PMID: 15821122 Free article. Review.
Testicular germ cell tumours (TGCT), including seminomas, embryonal carcinomas, teratomas and yolk sac tumours, have a common precursor, the carcinoma in situ (CIS) cell. ...Despite high cure rates of TGCT, efforts should be made to obtain diagnosis at the CIS stage …
Testicular germ cell tumours (TGCT), including seminomas, embryonal carcinomas, teratomas and yolk sac tumours, have a common precurs …
Clinical and biological significance of carcinoma in situ of the testis.
Jørgensen N, Müller J, Giwercman A, Skakkebaek NE. Jørgensen N, et al. Cancer Surv. 1990;9(2):287-302. Cancer Surv. 1990. PMID: 1964624 Review.
Carcinoma in situ (CIS) of the testis is a preinvasive lesion that with time progresses into invasive germ cell tumour. ...An increased risk of harbouring CIS has been reported in men with a history of cryptorchidism, in contralateral testes of men previously treated for u …
Carcinoma in situ (CIS) of the testis is a preinvasive lesion that with time progresses into invasive germ cell tumour. ...An increas …
39 results